Get started
Author

Wen‐Hui Ku

Observed names: W-H Ku, Wen-Hui Ku
ORCID: 0000-0002-4967-7018
Observed ORCID: 0000-0002-4967-7018
OpenAlex ID: A5047041592
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients
2018 · Kuo-Hsuan Hsu, Yen-Hsiang Huang, et al. · Lung Cancer · 105
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
2021 · Yao-Chun Hsu, Chi-Yi Chen, et al. · The Lancet Infectious Diseases · 61
The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis‐like T ‐cell lymphoma
2013 · Jau‐Yu Liau, Shih‐Sung Chuang, et al. · Histopathology · 59
Multimodality Treatment and Long-Term Follow–Up of the Primary Pulmonary Lymphoepithelioma-Like Carcinoma
2012 · Chung-Jen Huang, An-Chen Feng, et al. · Clinical Lung Cancer · 50
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
2021 · Yen-Ting Lin, Chi-Lu Chiang, et al. · European Journal of Cancer · 42
Characteristics and Predictive Value of PD-L1 Status in Real-World Non–Small Cell Lung Cancer Patients
2018 · Jeng-Sen Tseng, Tsung-Ying Yang, et al. · Journal of Immunotherapy · 38
FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2017 · Chia-Ying Hsu, Gee-Chen Chang, et al. · Clinical Cancer Research · 30
Genomic deletion and p53 inactivation in cervical carcinoma
1997 · Wen-Hui Ku, I-Ling Liu, et al. · International Journal of Cancer · 29
PDF
Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.
2016 · Te-Jen Su, Wen-Hui Ku, et al. · PubMed · 28
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
2016 · C-H Chen, W-H Chang, et al. · Oncogene · 27
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer
2022 · Sung-Liang Yu, Yi-Jing Hsiao, et al. · Pathology · 8
Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer
2019 · Hsiang-Ling Ho, Chao-Cheng Huang, et al. · Journal of the Chinese Medical Association · 8
Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing
2022 · Chi-Cheng Huang, Chih-Yi Liu, et al. · International Journal of Molecular Sciences · 2
PDF
Antigen-Presenting B-Cell Signature Predicts Response and Survival in HER2-Positive Breast Cancer
2026 · Po-Han Lin, Huang-Chun Lien, et al. · Research Square
PDF
Tumor Immune Response as a Biomarker for Metastasis-Free Survival of Breast Cancer and Immune Checkpoint Inhibition Therapy: A Retrospective Cohort Study
2025 · Chung-Wu Lin, Kai-Ming Chang, et al. · Breast Cancer Basic and Clinical Research
Supplementary Methods and Figure legends from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
PDF
Supplementary Figure S1-S13 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Supplementary Table S5 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Supplementary Tables S1-S8 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
PDF
Data from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Data from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Supplementary Methods and Figure legends from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Supplementary Table S5 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Supplementary Figure S1-S13 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
PDF
Supplementary Tables S1-S8 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
2023 · Chia-Ying Hsu, Gee-Chen Chang, et al.
Works count: 27
Citation count: 487
H-index: 10
I10-index: 10
Year
Topic
Type